Literature DB >> 15663956

Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas.

Monika Szeliga1, Marta Sidoryk, Ewa Matyja, Paweł Kowalczyk, Jan Albrecht.   

Abstract

In the central nervous system (CNS), liver-type glutaminase (LGA) shows a unique nuclear localization suggesting its role in the regulation of transcription rather than in the cellular glutamine metabolism. RT-PCR analysis of RNA derived from postoperative tissue samples revealed the absence or only traces of LGA mRNA in all (9) cases of malignant gliomas (astrocytoma anaplasticum, AA, WHO grade III; glioblastoma multiforme, WHO grade IV) examined. The RNA was strongly expressed in the non-neoplastic tissue derived from the same patients (6 cases), and in most of the brain metastases from different organs (5 out of 7 cases). By contrast, the mRNAs coding for the kidney-type glutaminase (KGA) and its less ubiquitous isoform GAC, which catalyze degradation of the cytoplasmic pool of Gln, were expressed in all the tissues examined. The lack of LGA may be thus considered as a useful negative diagnostic marker of highly malignant gliomas in situ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15663956     DOI: 10.1016/j.neulet.2004.10.051

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

2.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

3.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.

Authors:  Alexandre Cassago; Amanda P S Ferreira; Igor M Ferreira; Camila Fornezari; Emerson R M Gomes; Kai Su Greene; Humberto M Pereira; Richard C Garratt; Sandra M G Dias; Andre L B Ambrosio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

Review 4.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

Review 5.  Glutamine Addiction In Gliomas.

Authors:  Javier Márquez; Francisco J Alonso; José M Matés; Juan A Segura; Mercedes Martín-Rufián; José A Campos-Sandoval
Journal:  Neurochem Res       Date:  2017-03-09       Impact factor: 3.996

6.  Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors.

Authors:  Monika Szeliga; Ewa Matyja; Marta Obara; Wiesława Grajkowska; Tomasz Czernicki; Jan Albrecht
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

7.  Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.

Authors:  Nathan B Erdmann; Nick P Whitney; Jialin Zheng
Journal:  Clin Neurosci Res       Date:  2006-12

8.  Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Decai Yu; Xianbiao Shi; Gang Meng; Jun Chen; Chen Yan; Yong Jiang; Jiwu Wei; Yitao Ding
Journal:  Oncotarget       Date:  2015-04-10

9.  Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma.

Authors:  Sojin Kim; Ja Eun Kim; Yong Hwy Kim; Taeyoung Hwang; Sung Kwon Kim; Wen Jun Xu; Jong-Yeon Shin; Jong-Il Kim; Hyoungseon Choi; Hee Chan Kim; Hye Rim Cho; Anna Choi; Tamrin Chowdhury; Youngbeom Seo; Yun-Sik Dho; Jin Wook Kim; Dong Gyu Kim; Sung-Hye Park; Hyeonjin Kim; Seung Hong Choi; Sunghyouk Park; Se-Hoon Lee; Chul-Kee Park
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.

Authors:  Monika Szeliga; Małgorzata Bogacińska-Karaś; Aleksandra Różycka; Wojciech Hilgier; Javier Marquez; Jan Albrecht
Journal:  Tumour Biol       Date:  2013-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.